[go: up one dir, main page]

WO2018097189A1 - Stem cell isolation method and use of nonwoven fabric formed of norbornene-based polymer - Google Patents

Stem cell isolation method and use of nonwoven fabric formed of norbornene-based polymer Download PDF

Info

Publication number
WO2018097189A1
WO2018097189A1 PCT/JP2017/042042 JP2017042042W WO2018097189A1 WO 2018097189 A1 WO2018097189 A1 WO 2018097189A1 JP 2017042042 W JP2017042042 W JP 2017042042W WO 2018097189 A1 WO2018097189 A1 WO 2018097189A1
Authority
WO
WIPO (PCT)
Prior art keywords
nonwoven fabric
norbornene
cells
stem cells
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2017/042042
Other languages
French (fr)
Japanese (ja)
Inventor
石塚 保行
慧 足達
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofuture Technologies Ltd
Zeon Corp
Original Assignee
Biofuture Technologies Ltd
Zeon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofuture Technologies Ltd, Zeon Corp filed Critical Biofuture Technologies Ltd
Priority to JP2018552623A priority Critical patent/JP7018650B2/en
Publication of WO2018097189A1 publication Critical patent/WO2018097189A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus

Definitions

  • the present invention relates to a stem cell separation method for separating stem cells from a group of cells containing stem cells, and the use of a nonwoven fabric composed of a norbornene-based polymer for carrying out this method.
  • Patent Document 1 proposes a closed treatment system that obtains adipose tissue from a patient and administers stem cells concentrated by concentration treatment to the patient.
  • Stem cells used for such purposes are prepared from a group of adipose tissue cells obtained by liposuction surgery.
  • adipose tissue cell group usually, centrifugation or treatment with an enzyme such as collagenase is performed, and fat stem cells, fibroblasts, vascular endothelial cells, vascular smooth muscle-like cells, or the like
  • a group of stromal vascular cells composed of tissue-derived cells, blood-derived cells, and other cells is obtained (see, for example, Patent Document 2).
  • the cell group thus obtained contains various cells, and it is required to efficiently isolate stem cells from these cells.
  • Patent Document 4 proposes a method of culturing cells using a nonwoven fabric whose surface is coated with hydroxyapatite.
  • this method has a problem that it is difficult to ensure that the hydroxyapatite is uniformly coated on the surface of the nonwoven fabric, and that the hydroxyapatite applied to the nonwoven fabric is easily peeled off.
  • the present invention has been made in view of the actual situation of the prior art, and an object thereof is to easily selectively isolate and culture a specific stem cell by a simple culture operation.
  • the present inventors diligently studied a method for separating stem cells from a tissue-derived cell group.
  • adipose tissue-derived cell group is cultured on a nonwoven fabric in which at least the cell culture surface (culture surface) is composed of a norbornene polymer, only the adipose stem cells are exposed to the nonwoven fabric surface without any surface coating treatment.
  • adipose stem cells can be selectively separated and cultured, and as a result, adipose stem cells can be isolated, and the present invention has been completed.
  • the method for separating stem cells described in (1) and (2) below and the use of a nonwoven fabric composed of the norbornene polymer in (3).
  • a method for separating stem cells wherein a tissue-derived cell group containing stem cells is cultured on a nonwoven fabric having at least a culture surface made of a norbornene polymer.
  • specific stem cells can be easily selectively separated and cultured by a simple culture operation.
  • FIG. 1 is a phase contrast micrograph of mesenchymal stem cells (ASC) derived from adipose tissue 18 days after the start of culture growing on a ZEONOR nonwoven fabric in Example 1.
  • FIG. 2 is a phase contrast micrograph of ASC 18 days after the start of culture growing on the Zeonex nonwoven fabric 2 in Example 1.
  • FIG. 3 is a phase contrast micrograph of ASC subcultured in a flask for 4 days in Example 1.
  • FIG. 4 is a phase contrast micrograph of bone marrow-derived stem cells (BMSC) 18 days after the start of culture growing on the Zeonore nonwoven fabric in Example 2.
  • FIG. 5 is a phase contrast micrograph of BMSC 18 days after the start of culture growing on ZEONEX nonwoven fabric 1 in Example 2.
  • ASC mesenchymal stem cells
  • FIG. 6 is a phase contrast micrograph of BMSC subcultured in a flask for 4 days in Example 2.
  • FIG. FIG. 7 is a phase contrast micrograph of BMSC in a comparative example.
  • FIG. 8 is a phase contrast micrograph of BMSC in a comparative example.
  • FIG. 9 is a photomicrograph of adipocytes stained in Example 3.
  • FIG. 10 is a photomicrograph of stained osteoblasts in Example 3.
  • FIG. 11 is a photomicrograph of the chondrocytes stained in Example 3.
  • FIG. 12 is a fluorescence micrograph of nerve cells stained in Example 3.
  • a nonwoven fabric composed of a norbornene polymer used in the present invention is composed of a norbornene polymer having at least a cultured surface.
  • “at least the culture surface is composed of a norbornene-based polymer” means that at least the surface on which cells are cultured (the portion in contact with the cells, for example, the fibers constituting one surface of the nonwoven fabric) is norbornene-based. Means including a polymer.
  • the culture surface may be composed of only a norbornene polymer.
  • the nonwoven fabric used in the present invention can be used usually in various containers used for culturing cells.
  • the nonwoven fabric may float from the bottom surface of the container or may sink to the bottom surface of the container.
  • the cells may adhere to only one side of the nonwoven fabric or both sides, but from the viewpoint of cell retention, the nonwoven fabric covers the entire bottom surface of the container and adheres the cells to only one side of the nonwoven fabric. It is desirable to let it grow.
  • the material of the container in which the nonwoven fabric is put is not particularly limited, and a conventionally known container such as a polystyrene container or a glass container for cell culture can be used.
  • the norbornene-based polymer constituting the nonwoven fabric used in the present invention has a monomer unit having a norbornene skeleton in an amount of 50% by mass or more, preferably 60% by mass or more, based on all monomer units constituting the norbornene-based polymer. It is a polymer containing. More specifically, the norbornene polymer is obtained by polymerizing a norbornene monomer that is a monomer having a norbornene skeleton, and is obtained by ring-opening polymerization and by addition polymerization. It is divided roughly into.
  • Examples of the ring-opening polymer obtained by ring-opening polymerization include ring-opening polymers obtained by ring-opening polymerization of one or a mixture of two or more norbornene-based monomers, and norbornene-based monomers and ring-opening copolymers thereof. Examples thereof include ring-opening polymers obtained by ring-opening polymerization with other monomers, and hydrides thereof.
  • Examples of the polymers obtained by addition polymerization include addition polymers obtained by addition polymerization of one or a mixture of two or more norbornene monomers and other monomers copolymerizable with the norbornene monomers. And addition polymers obtained by addition polymerization.
  • a hydride of a ring-opening polymer obtained by ring-opening polymerization of one or a mixture of two or more norbornene-based monomers, or a norbornene-based single monomer since the effect of the present invention is more easily obtained, a hydride of a ring-opening polymer obtained by ring-opening polymerization of one or a mixture of two or more norbornene-based monomers, or a norbornene-based single monomer.
  • a hydride of a ring-opening polymer obtained by ring-opening polymerization of a monomer and this and another monomer capable of ring-opening copolymerization is preferred, and one or a mixture of two or more norbornene monomers is opened.
  • a hydride of a ring-opening polymer obtained by ring polymerization is more preferable.
  • norbornene monomers that can be used for the synthesis of norbornene polymers include bicyclo [2.2.1] hept-2-ene (commonly known as norbornene) and 5-methyl-bicyclo [2.2.1] hepta.
  • deca-3,7-diene (common name dicyclopentadiene), 2-methyldicyclopentadiene, 2,3-dimethyldicyclopentadiene, 2,3-dihydroxydicyclopentadiene, etc. Mer; Tetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene (tetracyclododecene), tetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-methyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-ethyltetracyclo [4.4.0.1 2,5 .
  • dec-3-ene (common name methanotetrahydrofluorene: also called 1,4-methano-1,4,4a, 9a-tetrahydrofluorene) 1,4-methano-8-methyl-1,4,4a, 9a-tetrahydrofluorene, 1,4-methano-8-chloro-1,4,4a, 9a-tetrahydrofluorene, 1,4-methano-8 -Tetracyclic monomers such as bromo-1,4,4a, 9a-tetrahydrofluorene;
  • These norbornene monomers may have one or more substituents.
  • substituents include an alkyl group, an alkylene group, an aryl group, a silyl group, an alkoxycarbonyl group, and an alkylidene group.
  • monomers capable of ring-opening copolymerization with norbornene monomers include cyclohexene, cycloheptene, cyclooctene, 1,4-cyclohexadiene, 1,5-cyclooctadiene, 1,5-cyclodecadiene, And monocyclic cycloolefin monomers such as 1,5,9-cyclododecatriene and 1,5,9,13-cyclohexadecatetraene.
  • ⁇ -olefin monomers having 2 to 20 carbon atoms such as ethylene, propylene, 1-butene, 1-pentene and 1-hexene; cyclobutene, cyclopentene, cyclohexene, cyclooctene, tetracyclo [9.2.1.0 2,10.
  • Cycloolefin monomers such as 0 3,8 ] tetradeca-3,5,7,12-tetraene (also referred to as 3a, 5,6,7a-tetrahydro-4,7-methano-1H-indene);
  • Non-conjugated diene monomers such as 4-hexadiene, 4-methyl-1,4-hexadiene, 5-methyl-1,4-hexadiene, 1,7-octadiene, and the like.
  • ⁇ -olefin monomers are preferable, and ethylene is more preferable.
  • These other monomers may have one or more substituents. Examples of the substituent include an alkyl group, an alkylene group, an aryl group, a silyl group, an alkoxycarbonyl group, and an alkylidene group.
  • a ring-opening polymer of a norbornene-based monomer, or a ring-opening polymer of a norbornene-based monomer and another monomer capable of ring-opening copolymerization with a monomer component is a known ring-opening polymerization. It can be obtained by polymerization in the presence of a catalyst.
  • the ring-opening polymerization catalyst include a catalyst comprising a metal halide such as ruthenium or osmium, a nitrate or an acetylacetone compound, and a reducing agent, or a metal halide or acetylacetone such as titanium, zirconium, tungsten, or molybdenum.
  • a catalyst comprising a compound and an organoaluminum compound can be used.
  • the ring-opening polymer hydride of a norbornene-based monomer is usually obtained by adding a known hydrogenation catalyst containing a transition metal such as nickel or palladium to the polymerization solution of the ring-opening polymer and then adding a carbon-carbon unsaturated bond. Can be obtained by hydrogenation.
  • a catalyst composed of a titanium, zirconium or vanadium compound and an organoaluminum compound can be used.
  • the molecular weight of the norbornene polymer is usually a weight average molecular weight in terms of polystyrene measured by gel permeation chromatography (GPC) of a cyclohexane solution (or a toluene solution if the polymer does not dissolve). It is 5,000 or more, preferably 5,000 to 500,000, more preferably 8,000 to 200,000, and particularly preferably 10,000 to 100,000. When the weight average molecular weight is within this range, the mechanical strength and the moldability are highly balanced, which is preferable.
  • GPC gel permeation chromatography
  • the glass transition temperature of the norbornene polymer may be appropriately selected depending on the purpose of use, but is usually 50 to 300 ° C., preferably 100 to 280 ° C., particularly preferably 115 to 250 ° C., and more preferably 130 to 200 ° C. ° C. When the glass transition temperature is within this range, heat resistance and molding processability are highly balanced and suitable. In the present invention, the glass transition temperature is measured based on JIS K7121.
  • the norbornene polymers can be used alone or in combination of two or more.
  • a compounding agent usually used in thermoplastic resin materials for example, a soft polymer, an antioxidant, an ultraviolet absorber, a light stabilizer Additives, near-infrared absorbers, release agents, colorants such as dyes and pigments, plasticizers, antistatic agents, fluorescent whitening agents, and other compounding agents can be added in the amounts usually employed.
  • a soft polymer when used in combination with a norbornene polymer, it is usually 0.01 to 20 parts by mass with respect to 100 parts by mass of the alicyclic structure-containing polymer that is a norbornene polymer.
  • the amount is preferably 0.05 to 10 parts by mass, more preferably 0.05 to 5 parts by mass.
  • other polymers are mixed as the resin component constituting the nonwoven fabric. May be.
  • the amount of the other polymer mixed with the norbornene polymer is usually 200 parts by mass or less, preferably 150 parts by mass or less, and more preferably 100 parts by mass or less with respect to 100 parts by mass of the norbornene polymer. If the proportion of various compounding agents and other polymers to be blended with respect to the norbornene polymer is too large, the cells are difficult to float. Therefore, it is preferable to blend them in a range that does not impair the properties of the norbornene polymer.
  • the mixing method of the norbornene polymer and the compounding agent or other polymer is not particularly limited as long as the compounding agent is sufficiently dispersed in the polymer. Moreover, there is no special restriction
  • a blending method for example, a method of kneading a resin in a molten state using a mixer, a uniaxial kneader, a biaxial kneader, a roll, a Brabender, an extruder, etc., after dissolving and dispersing in a suitable solvent, Examples thereof include a method of removing the solvent by a coagulation method, a casting method, or a direct drying method.
  • a biaxial kneader is used, after kneading, it is usually extruded in a rod shape in a molten state, cut into an appropriate length with a strand cutter, and pelletized in many cases.
  • the manufacturing method of a general nonwoven fabric can be employ
  • the method using a melt blow method is employ
  • the fiber diameter of the nonwoven fabric used in the present invention is preferably 10 to 20 ⁇ m.
  • the fiber diameter is a value measured by photographing the surface of the nonwoven fabric using a digital microscope VHX-1000 (manufactured by Keyence Corporation).
  • the basis weight of the nonwoven fabric is preferably 0.8 mg / cm 2 to 1.0 mg / cm 2 .
  • the basis weight is a value obtained by calculating the weight per unit area from the weight of the 3 cm square nonwoven fabric.
  • the surface coverage of the nonwoven fabric is preferably 50% to 95%.
  • the surface coverage is the area of the entire image obtained by removing the voids where no fibers are present from the entire area of the image taken with the digital microscope using image analysis software (Image J). It is a value converted by dividing from.
  • the nonwoven fabric used in the present invention is usually used after sterilization.
  • heating methods such as the high-pressure steam method and dry heat method; radiation methods that irradiate radiation such as gamma rays and electron beams; irradiation methods that irradiate high frequencies; ethylene oxide gas (EOG)
  • EOG ethylene oxide gas
  • the method can be arbitrarily selected from methods generally employed in the medical field, such as a gas method in which a gas is brought into contact, a filtration method using a sterilizing filter, and the like.
  • the tissue-derived cell group containing stem cells cultured on the nonwoven fabric used in the present invention is not particularly limited as long as it is a tissue-derived cell group containing a plurality of types of cells including stem cells. Examples thereof include a mesenchymal vascular cell group, a fat-derived cell group, and a bone marrow-derived cell group that are used for cell therapy. In addition, some cells may be already separated from these cell groups.
  • the medium for separating the stem cells from the tissue-derived cell group using such a non-woven fabric may be a medium capable of growing the stem cells to be separated, and can be grown particularly while maintaining undifferentiation. It is preferable to use a medium.
  • a medium is commercially available. For example, if it is an adipose-derived stem cell, the KBM ADSC series manufactured by Kojin Bio Co., Ltd. can be used. If it is a bone marrow-derived stem cell, Stemline, a mesenchymal system manufactured by SIGMA-ALDRICH Stem cell growth medium series etc. are mentioned.
  • additives can also be mix
  • additives include inducers such as proteins, minerals, metals, vitamin components, and the like. These additives can be used alone or in combination of two or more.
  • the cell culture conditions are not particularly limited, and can be appropriately determined according to the cells to be used and the purpose.
  • the cells can be cultured using a humidified thermostat having a carbon dioxide concentration of about 5% and a constant temperature in the range of 20 ° C. to 37 ° C.
  • tissue-derived cell group when a tissue-derived cell group is cultured on a nonwoven fabric having at least a culture surface made of a norbornene polymer, only adipose stem cells can be adhered and cultured, and as a result, adipose stem cells are separated. It can be done.
  • the isolated stem cells can be used for stem cell therapy, and further cultured in a differentiation-inducing medium to obtain differentiated cells, which can be used for drug discovery and medical applications.
  • the medium used in inducing differentiation of the stem cells isolated by the method of the present invention may be a medium suitable for inducing differentiation of stem cells, a medium to which an additive for inducing differentiation into a basal medium is added, A commercially available differentiation induction medium can be used.
  • Additives for inducing differentiation include ligands, agonists and antagonists acting on cell surface receptors; nuclear receptors, ligands, agonists and antagonists; extracellular matrix such as collagen and fivenectin; extracellular matrix A compound that acts on a protein involved in an intracellular signal transduction pathway; a component that acts on an enzyme of primary or secondary metabolism in a cell; a gene in a nucleus or mitochondrion in a cell Examples include components that affect expression; DNA and RNA that can be introduced into cells in combination with viral vectors and the like. These additives can be used alone or in combination of two or more. Examples of the commercially available differentiation induction medium include “Stem Cell Kits” manufactured by R & D Systems.
  • the cell culture conditions are not particularly limited, and can be appropriately determined according to the cells to be used and the purpose.
  • the cells can be cultured using a humidified thermostat having a carbon dioxide concentration of about 5% and a constant temperature in the range of 20 ° C. to 37 ° C.
  • Norbornene-based polymer Zeonor (registered trademark) 1060R, manufactured by Nippon Zeon Co., Ltd .; norbornene-based ring-opening polymer hydride), and norbornene-based polymer (Zeonex (registered trademark) 5000, manufactured by Nippon Zeon Co., Ltd .; norbornene-based ring opening Polymer hydride
  • ZEONOR registered trademark
  • ZEONOR nonwoven fabric two types of products made of ZEONEX (registered trademark) 5000 Nonwoven fabrics (hereinafter referred to as “ZEONEX nonwoven fabric 1” and “ZEONEX nonwoven fabric 2”) were produced.
  • ⁇ ZEONEX nonwoven fabric 1> Resin: Zeonex (registered trademark) 5000 ⁇ Nozzle temperature: 300 °C -Die temperature: 290 ° C ⁇ Rotation speed: 100rpm ⁇ Conveyor speed: 14.2 m / min DCD: 85mm
  • ⁇ ZEONEX nonwoven fabric 2> Resin: Zeonex (registered trademark) 5000 ⁇ Nozzle temperature: 298 °C -Die temperature: 290 ° C ⁇ Rotation speed: 100rpm ⁇ Conveyor speed: 14.2 m / min DCD: 52mm
  • the fiber diameter, basis weight, and surface coverage of the obtained nonwoven fabric are as follows. ⁇ Zeonoa nonwoven fabric: Fiber diameter 10.05 ⁇ m, basis weight 0.98 mg / cm 2 , surface coverage 91% ZEONEX nonwoven fabric 1: Fiber diameter 15.05 ⁇ m, basis weight 0.94 mg / cm 2 , surface coverage 58% ZEONEX nonwoven fabric 2: fiber diameter 13.33 ⁇ m, basis weight 0.81 mg / cm 2 , surface coverage 82%
  • Example 1 ⁇ Separation of ASC from adipose tissue> A fat tissue with a diameter of about 3 mm extracted from a human is divided into four parts, and this is placed on a ZEONOR nonwoven fabric and a ZEONEX nonwoven fabric 2 cut into a circular shape with a diameter of 2 cm. It was put in a polystyrene dish (FALCON (registered trademark), Corning, TCPS having a diameter of 35 mm). Thereafter, a mesenchymal stem cell growth medium (Stemline (registered trademark), manufactured by Sigma-Aldrich) supplemented with 2% fetal bovine serum (FBS) was added to the dish, and cultured at 37 ° C.
  • FALCON registered trademark
  • TCPS a mesenchymal stem cell growth medium
  • FBS fetal bovine serum
  • ASC adipose tissue-derived stem cells
  • FIG. 3 shows a phase contrast micrograph (magnification 64 times) when transferred to a cell culture flask and subcultured for 4 days. It is confirmed that ASC is proliferating.
  • HBSS Hanks Balanced Salt Solution
  • BMSC bone marrow-derived stem cells
  • BMSC was peeled off from the nonwoven fabric with trypsin-EDTA, transferred to a 279.8 mL flask for cell culture (model number “T-75”, manufactured by Eppendorf), and subcultured for 4 days in the same medium. It was 90% confluent.
  • 4 and 5 show phase contrast micrographs (magnification 64 times) of BMSC grown on the Zeonore nonwoven fabric and the Zeonex nonwoven fabric 1 after 18 days from the start of culture. It is confirmed that BMSC is proliferating on any nonwoven fabric.
  • FIG. 6 shows a phase contrast micrograph (magnification 64 times) when this BMSC was transferred to a cell culture flask and subcultured for 4 days. It is confirmed that BMSC is proliferating.
  • a 6-well plate was placed in a core polyethylene outer layer polypropylene non-woven fabric (10 mm ⁇ 32 mm), and a suspension of BMSC, 3 mL (0.45 ⁇ 10 6 cells / mL) was added thereto and cultured for 3 days.
  • the medium was a mesenchymal stem cell growth medium (Sigma Aldrich, Stemline (registered trademark)) supplemented with 2% FBS.
  • MSC was only slightly adhered on the core polyethylene outer layer polypropylene non-woven fabric (FIG. 7) and adhered to the bottom surface of the plate in a 100% confluent state (FIG. 8). The effect was not obtained.
  • Example 3 the differentiation induction experiment of ASC separated on the ZEONOR nonwoven fabric and the ZEONEX nonwoven fabric 2 and then passaged (hereinafter referred to as “passage ASC”) was performed as follows.
  • a Differentiation into adipocytes Passage ASC was seeded on a 24-well multiplate (FALCON (registered trademark) model No. 353047, manufactured by Corning) at 1.9 ⁇ 10 5 cells / well, and 2% fetal bovine serum ( A mesenchymal stem cell growth medium (Stemline (registered trademark), manufactured by Sigma-Aldrich) supplemented with FBS) was added and cultured under conditions of 37 ° C. in a 5% CO 2 atmosphere.
  • FALCON registered trademark
  • Stema mesenchymal stem cell growth medium (Stemline (registered trademark), manufactured by Sigma-Aldrich) supplemented with FBS
  • Example 1 After 24 hours, the medium was discarded, washed twice with a phosphate buffer (PBS), replaced with an adipocyte differentiation medium (model number BBDM2, DS Pharma Biomedical), and cultured for 1 week. Thereafter, the medium was replaced with an adipocyte culture medium (model number BBAM1, manufactured by DS Pharma Biomedical Co., Ltd.), cultured for 1 week, and then stained with Oil-Red.
  • PBS phosphate buffer
  • BBDM2 adipocyte differentiation medium
  • BBAM1 adipocyte culture medium
  • FIG. 10 shows a photomicrograph of stained osteoblasts. From FIG. 10, since the cells and their surroundings were stained with Alizarin Red in light red, calcium deposition was observed, and the passage ASC obtained in Example 1 also has the ability to differentiate into osteoblasts. Was confirmed.
  • Example 1 since the cells and their surroundings were stained blue with Alcian Blue, the deposition of acidic mucopolysaccharides abundant in cartilage was observed, and the passage ASC obtained in Example 1 differentiated into chondrocytes. It was confirmed that it also has a function.
  • FIG. 12 shows a fluorescence micrograph in which nerve cells are stained. From FIG. 12, since the cell bodies and processes are stained green, it is recognized that the cells are mature mammalian neurons, and the passage ASC obtained in Example 1 also has the ability to differentiate into neurons. It was confirmed to have.

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The present invention selectively isolates and cultures a specific stem cell with ease by means of a simple culturing operation. Provided is a method for isolating stem cells, wherein a group of tissue-derived cells including stem cells is cultured on a nonwoven fabric in which at least a culturing surface thereof is formed of a norbornene-based polymer.

Description

幹細胞の分離方法及びノルボルネン系重合体で構成される不織布の使用Method for separating stem cells and use of non-woven fabric composed of norbornene polymer

 本発明は、幹細胞を含む細胞群から幹細胞を分離する幹細胞の分離方法、及びこの方法を実施するためのノルボルネン系重合体で構成される不織布の使用に関する。 The present invention relates to a stem cell separation method for separating stem cells from a group of cells containing stem cells, and the use of a nonwoven fabric composed of a norbornene-based polymer for carrying out this method.

 近年、幹細胞又は幹細胞から派生した細胞を用いて、ダメージを受けた患者の細胞や組織を修復したり再生したりする幹細胞治療の開発が進んでいる。例えば、特許文献1には、患者から脂肪組織を取得し、濃縮処理により濃縮された幹細胞を患者へ投与する閉鎖系の治療システムが提案されている。 In recent years, the development of stem cell therapy that repairs or regenerates cells and tissues of damaged patients using stem cells or cells derived from stem cells has been progressing. For example, Patent Document 1 proposes a closed treatment system that obtains adipose tissue from a patient and administers stem cells concentrated by concentration treatment to the patient.

 こうした目的に用いられる幹細胞は、脂肪吸引手術により取得された脂肪組織細胞群などから調製される。採取された脂肪組織細胞群から幹細胞を取得するためには、通常、遠心分離処理やコラゲナーゼ等の酵素による処理を行い、脂肪幹細胞や繊維芽細胞や血管内皮細胞や血管平滑筋様細胞などの脂肪組織由来細胞と血液由来細胞とその他の細胞とからなる間質血管細胞群を得る(例えば、特許文献2参照)。 Stem cells used for such purposes are prepared from a group of adipose tissue cells obtained by liposuction surgery. In order to obtain stem cells from the collected adipose tissue cell group, usually, centrifugation or treatment with an enzyme such as collagenase is performed, and fat stem cells, fibroblasts, vascular endothelial cells, vascular smooth muscle-like cells, or the like A group of stromal vascular cells composed of tissue-derived cells, blood-derived cells, and other cells is obtained (see, for example, Patent Document 2).

国際公開第03/053346号International Publication No. 03/053346 国際公開第2005/042730号International Publication No. 2005/042730 特開2013-034436号公報JP 2013-034436 A 特開2008-199897号公報JP 2008-199897 A

 このようにして得られた細胞群にも様々な細胞が含まれており、この中から幹細胞を効率よく単離することが求められている。 The cell group thus obtained contains various cells, and it is required to efficiently isolate stem cells from these cells.

 不織布を幹細胞の分離に用いる例は多くあり、通常、特許文献3などに記載されているように、不織布は濾過基材として用いられている。しかしながら、この方法では、細胞の懸濁液を調製する必要があり、懸濁液の濃度調整なども必要となる。
 一方、細胞の懸濁液を用いない方法として、特許文献4では、ハイドロキシアパタイトで表面をコートした不織布を用いて細胞を培養する方法が提案されている。しかしながら、この方法は、不織布表面のハイドロキシアパタイトが均一にコートされていることを担保することが難しいことに加え、不織布に塗布されたハイドロキシアパタイトが剥離しやすいという問題を有している。
There are many examples of using a nonwoven fabric for the separation of stem cells, and as described in Patent Document 3 and the like, the nonwoven fabric is usually used as a filtration substrate. However, in this method, it is necessary to prepare a suspension of cells, and it is also necessary to adjust the concentration of the suspension.
On the other hand, as a method not using a cell suspension, Patent Document 4 proposes a method of culturing cells using a nonwoven fabric whose surface is coated with hydroxyapatite. However, this method has a problem that it is difficult to ensure that the hydroxyapatite is uniformly coated on the surface of the nonwoven fabric, and that the hydroxyapatite applied to the nonwoven fabric is easily peeled off.

 本発明は、かかる従来技術の実情に鑑みてなされたものであり、単純な培養操作で、容易に特定の幹細胞を選択的に分離培養することを課題とする。 The present invention has been made in view of the actual situation of the prior art, and an object thereof is to easily selectively isolate and culture a specific stem cell by a simple culture operation.

 本発明者らは、上記課題を解決すべく、組織由来細胞群からの幹細胞の分離方法について鋭意検討を行った。
 その結果、少なくとも細胞を培養する面(培養面)がノルボルネン系重合体で構成される不織布上で、脂肪組織由来細胞群を培養すると、表面コート処理などをしなくても脂肪幹細胞のみが不織布表面に接着するため、脂肪幹細胞を選択的に分離培養することができ、結果として、脂肪幹細胞を分離することができることを見出し、本発明を完成するに至った。
In order to solve the above-mentioned problems, the present inventors diligently studied a method for separating stem cells from a tissue-derived cell group.
As a result, when the adipose tissue-derived cell group is cultured on a nonwoven fabric in which at least the cell culture surface (culture surface) is composed of a norbornene polymer, only the adipose stem cells are exposed to the nonwoven fabric surface without any surface coating treatment. As a result, it was found that adipose stem cells can be selectively separated and cultured, and as a result, adipose stem cells can be isolated, and the present invention has been completed.

 かくして本発明によれば、下記(1)、(2)の幹細胞の分離方法、及び(3)のノルボルネン系重合体で構成される不織布の使用が提供される。
(1)幹細胞を含む組織由来細胞群を、少なくとも培養面がノルボルネン系重合体で構成される不織布上で培養する、幹細胞の分離方法。
(2)前記組織由来細胞群が、脂肪組織由来の細胞群である、(1)に記載の幹細胞の分離方法。
(3)幹細胞を含む組織由来細胞群から幹細胞を分離するための、少なくとも培養面がノルボルネン系重合体で構成される不織布の使用。
Thus, according to the present invention, there are provided the method for separating stem cells described in (1) and (2) below, and the use of a nonwoven fabric composed of the norbornene polymer in (3).
(1) A method for separating stem cells, wherein a tissue-derived cell group containing stem cells is cultured on a nonwoven fabric having at least a culture surface made of a norbornene polymer.
(2) The method for separating stem cells according to (1), wherein the tissue-derived cell group is a group of cells derived from adipose tissue.
(3) Use of a nonwoven fabric in which at least the culture surface is composed of a norbornene polymer for separating stem cells from a tissue-derived cell group containing stem cells.

 本発明によれば、単純な培養操作で、容易に特定の幹細胞を選択的に分離培養することができる。 According to the present invention, specific stem cells can be easily selectively separated and cultured by a simple culture operation.

図1は、実施例1におけるゼオノア不織布上に増殖している培養開始から18日後の脂肪組織由来の間葉系幹細胞(ASC)の位相差顕微鏡写真である。FIG. 1 is a phase contrast micrograph of mesenchymal stem cells (ASC) derived from adipose tissue 18 days after the start of culture growing on a ZEONOR nonwoven fabric in Example 1. 図2は、実施例1におけるゼオネックス不織布2上に増殖している培養開始から18日後のASCの位相差顕微鏡写真である。FIG. 2 is a phase contrast micrograph of ASC 18 days after the start of culture growing on the Zeonex nonwoven fabric 2 in Example 1. 図3は、実施例1において、フラスコ内で4日間継代培養したASCの位相差顕微鏡写真である。FIG. 3 is a phase contrast micrograph of ASC subcultured in a flask for 4 days in Example 1. 図4は、実施例2におけるゼオノア不織布上に増殖している培養開始から18日後の骨髄由来幹細胞(BMSC)の位相差顕微鏡写真である。FIG. 4 is a phase contrast micrograph of bone marrow-derived stem cells (BMSC) 18 days after the start of culture growing on the Zeonore nonwoven fabric in Example 2. 図5は、実施例2におけるゼオネックス不織布1上に増殖している培養開始から18日後のBMSCの位相差顕微鏡写真である。FIG. 5 is a phase contrast micrograph of BMSC 18 days after the start of culture growing on ZEONEX nonwoven fabric 1 in Example 2. 図6は、実施例2において、フラスコ内で4日間継代培養したBMSCの位相差顕微鏡写真である。6 is a phase contrast micrograph of BMSC subcultured in a flask for 4 days in Example 2. FIG. 図7は、比較例におけるBMSCの位相差顕微鏡写真である。FIG. 7 is a phase contrast micrograph of BMSC in a comparative example. 図8は、比較例におけるBMSCの位相差顕微鏡写真である。FIG. 8 is a phase contrast micrograph of BMSC in a comparative example. 図9は、実施例3における脂肪細胞が染色された顕微鏡写真である。FIG. 9 is a photomicrograph of adipocytes stained in Example 3. 図10は、実施例3における骨芽細胞が染色された顕微鏡写真である。FIG. 10 is a photomicrograph of stained osteoblasts in Example 3. 図11は、実施例3における軟骨細胞が染色された顕微鏡写真である。FIG. 11 is a photomicrograph of the chondrocytes stained in Example 3. 図12は、実施例3における神経細胞が染色された蛍光顕微鏡写真である。FIG. 12 is a fluorescence micrograph of nerve cells stained in Example 3.

 以下、本発明の実施形態について詳細に説明する。
 本発明に用いるノルボルネン系重合体で構成される不織布(以下、単に「本発明に用いる不織布」又は「不織布」ということがある)は、少なくとも培養面が繊維状のノルボルネン系重合体で構成されるものである。
 本発明の不織布において、「少なくとも培養面がノルボルネン系重合体で構成される」とは、少なくとも細胞を培養する面(細胞と接触する部分、例えば、不織布の片面を構成する繊維)が、ノルボルネン系重合体を含むことを意味する。なお、培養面がノルボルネン系重合体のみからなることとしてもよい。
Hereinafter, embodiments of the present invention will be described in detail.
A nonwoven fabric composed of a norbornene polymer used in the present invention (hereinafter sometimes simply referred to as “nonwoven fabric used in the present invention” or “nonwoven fabric”) is composed of a norbornene polymer having at least a cultured surface. Is.
In the nonwoven fabric of the present invention, “at least the culture surface is composed of a norbornene-based polymer” means that at least the surface on which cells are cultured (the portion in contact with the cells, for example, the fibers constituting one surface of the nonwoven fabric) is norbornene-based. Means including a polymer. The culture surface may be composed of only a norbornene polymer.

 本発明に用いる不織布は、通常、細胞を培養するのに用いられる様々な容器の中に入れて用いることができる。不織布は容器底面から浮いていても、容器底面に沈んでいても良い。また、細胞は不織布の片面のみに接着していても、両面に接着していても良いが、細胞の保持性の観点から、不織布は容器の底面全面を覆い、不織布の片面のみに細胞を接着させ、増殖させることが望ましい。
 不織布を入れる容器の材質は特に制限されず、細胞培養用のポリスチレン製容器やガラス容器などの従来公知の容器を用いることができる。
The nonwoven fabric used in the present invention can be used usually in various containers used for culturing cells. The nonwoven fabric may float from the bottom surface of the container or may sink to the bottom surface of the container. In addition, the cells may adhere to only one side of the nonwoven fabric or both sides, but from the viewpoint of cell retention, the nonwoven fabric covers the entire bottom surface of the container and adheres the cells to only one side of the nonwoven fabric. It is desirable to let it grow.
The material of the container in which the nonwoven fabric is put is not particularly limited, and a conventionally known container such as a polystyrene container or a glass container for cell culture can be used.

 本発明に用いる不織布を構成するノルボルネン系重合体は、ノルボルネン骨格を有する単量体単位を、ノルボルネン系重合体を構成する全単量体単位に対して50質量%以上、好ましくは60質量%以上含む重合体である。より具体的には、ノルボルネン系重合体は、ノルボルネン骨格を有する単量体であるノルボルネン系単量体を重合してなるものであり、開環重合によって得られるものと、付加重合によって得られるものに大別される。 The norbornene-based polymer constituting the nonwoven fabric used in the present invention has a monomer unit having a norbornene skeleton in an amount of 50% by mass or more, preferably 60% by mass or more, based on all monomer units constituting the norbornene-based polymer. It is a polymer containing. More specifically, the norbornene polymer is obtained by polymerizing a norbornene monomer that is a monomer having a norbornene skeleton, and is obtained by ring-opening polymerization and by addition polymerization. It is divided roughly into.

 開環重合によって得られるものとしては、ノルボルネン系単量体の一種若しくは二種以上の混合物を開環重合して得られる開環重合体、ノルボルネン系単量体とこれと開環共重合可能なその他の単量体とを開環重合して得られる開環重合体、及び、これらの水素化物などが挙げられる。
 付加重合によって得られるものとしては、ノルボルネン系単量体の一種若しくは二種以上の混合物を付加重合して得られる付加重合体及びノルボルネン系単量体とこれと共重合可能なその他の単量体とを付加重合して得られる付加重合体などが挙げられる。
 これらの中でも、本願発明の効果がより得られ易いことから、ノルボルネン系単量体の一種若しくは二種以上の混合物を開環重合して得られる開環重合体の水素化物、又は、ノルボルネン系単量体とこれと開環共重合可能なその他の単量体とを開環重合して得られる開環重合体の水素化物が好ましく、ノルボルネン系単量体の一種若しくは二種以上の混合物を開環重合して得られる開環重合体の水素化物がより好ましい。
Examples of the ring-opening polymer obtained by ring-opening polymerization include ring-opening polymers obtained by ring-opening polymerization of one or a mixture of two or more norbornene-based monomers, and norbornene-based monomers and ring-opening copolymers thereof. Examples thereof include ring-opening polymers obtained by ring-opening polymerization with other monomers, and hydrides thereof.
Examples of the polymers obtained by addition polymerization include addition polymers obtained by addition polymerization of one or a mixture of two or more norbornene monomers and other monomers copolymerizable with the norbornene monomers. And addition polymers obtained by addition polymerization.
Among these, since the effect of the present invention is more easily obtained, a hydride of a ring-opening polymer obtained by ring-opening polymerization of one or a mixture of two or more norbornene-based monomers, or a norbornene-based single monomer. A hydride of a ring-opening polymer obtained by ring-opening polymerization of a monomer and this and another monomer capable of ring-opening copolymerization is preferred, and one or a mixture of two or more norbornene monomers is opened. A hydride of a ring-opening polymer obtained by ring polymerization is more preferable.

 ノルボルネン系重合体の合成に使用可能なノルボルネン系単量体としては、ビシクロ[2.2.1]ヘプタ-2-エン(慣用名ノルボルネン)、5-メチル-ビシクロ[2.2.1]ヘプタ-2-エン、5,5-ジメチル-ビシクロ[2.2.1]ヘプタ-2-エン、5-エチル-ビシクロ[2.2.1]ヘプタ-2-エン、5-エチリデン-ビシクロ[2.2.1]ヘプタ-2-エン、5-ビニル-ビシクロ[2.2.1]ヘプタ-2-エン、5-プロペニルビシクロ[2.2.1]ヘプタ-2-エン、5-メトキシカルボニル-ビシクロ[2.2.1]ヘプタ-2-エン、5-シアノビシクロ[2.2.1]ヘプタ-2-エン、5-メチル-5-メトキシカルボニル-ビシクロ[2.2.1]ヘプタ-2-エン等の2環式単量体;
 トリシクロ[4.3.01,6.12,5]デカ-3,7-ジエン(慣用名ジシクロペンタジエン)、2-メチルジシクロペンタジエン、2,3-ジメチルジシクロペンタジエン、2,3-ジヒドロキシジシクロペンタジエン等の3環式単量体;
 テトラシクロ[4.4.0.12,5.17,10]-3-ドデセン(テトラシクロドデセン)、テトラシクロ[4.4.0.12,5.17,10]-3-ドデセン、8-メチルテトラシクロ[4.4.0.12,5.17,10]-3-ドデセン、8-エチルテトラシクロ[4.4.0.12,5.17,10]-3-ドデセン、8-エチリデンテトラシクロ[4.4.0.12,5.17,10]-3-ドデセン、8,9-ジメチルテトラシクロ[4.4.0.12,5.17,10]-3-ドデセン、8-エチル-9-メチルテトラシクロ[4.4.0.12,5.17,10]-3-ドデセン、8-エチリデン-9-メチルテトラシクロ[4.4.0.12,5.17,10]-3-ドデセン、8-メチル-8-カルボキシメチルテトラシクロ[4.4.0.12,5.17,10]-3-ドデセン、
 7,8-ベンゾトリシクロ[4.3.0.12,5]デカ-3-エン(慣用名メタノテトラヒドロフルオレン:1,4-メタノ-1,4,4a,9a-テトラヒドロフルオレンともいう)、1,4-メタノ-8-メチル-1,4,4a,9a-テトラヒドロフルオレン、1,4-メタノ-8-クロロ-1,4,4a,9a-テトラヒドロフルオレン、1,4-メタノ-8-ブロモ-1,4,4a,9a-テトラヒドロフルオレン等の4環式単量体;等が挙げられる。
 これらのノルボルネン系単量体は、置換基を1種又は2種以上有していてもよい。置換基としては、アルキル基、アルキレン基、アリール基、シリル基、アルコキシカルボニル基、アルキリデン基等が挙げられる。
Examples of norbornene monomers that can be used for the synthesis of norbornene polymers include bicyclo [2.2.1] hept-2-ene (commonly known as norbornene) and 5-methyl-bicyclo [2.2.1] hepta. -2-ene, 5,5-dimethyl-bicyclo [2.2.1] hept-2-ene, 5-ethyl-bicyclo [2.2.1] hept-2-ene, 5-ethylidene-bicyclo [2 2.1] hept-2-ene, 5-vinyl-bicyclo [2.2.1] hept-2-ene, 5-propenylbicyclo [2.2.1] hept-2-ene, 5-methoxycarbonyl -Bicyclo [2.2.1] hept-2-ene, 5-cyanobicyclo [2.2.1] hept-2-ene, 5-methyl-5-methoxycarbonyl-bicyclo [2.2.1] hepta -Bicyclic monomers such as 2-ene;
Tricyclo [4.3.0 1,6 . 1 2,5 ] deca-3,7-diene (common name dicyclopentadiene), 2-methyldicyclopentadiene, 2,3-dimethyldicyclopentadiene, 2,3-dihydroxydicyclopentadiene, etc. Mer;
Tetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene (tetracyclododecene), tetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-methyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-ethyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-ethylidenetetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8,9-dimethyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-ethyl-9-methyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-ethylidene-9-methyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene, 8-methyl-8-carboxymethyltetracyclo [4.4.0.1 2,5 . 1 7,10 ] -3-dodecene,
7,8-benzotricyclo [4.3.0.1 2,5 ] dec-3-ene (common name methanotetrahydrofluorene: also called 1,4-methano-1,4,4a, 9a-tetrahydrofluorene) 1,4-methano-8-methyl-1,4,4a, 9a-tetrahydrofluorene, 1,4-methano-8-chloro-1,4,4a, 9a-tetrahydrofluorene, 1,4-methano-8 -Tetracyclic monomers such as bromo-1,4,4a, 9a-tetrahydrofluorene;
These norbornene monomers may have one or more substituents. Examples of the substituent include an alkyl group, an alkylene group, an aryl group, a silyl group, an alkoxycarbonyl group, and an alkylidene group.

 ノルボルネン系単量体と開環共重合可能なその他の単量体としては、シクロヘキセン、シクロヘプテン、シクロオクテン、1,4-シクロヘキサジエン、1,5-シクロオクタジエン、1,5-シクロデカジエン、1,5,9-シクロドデカトリエン、1,5,9,13-シクロヘキサデカテトラエン等の単環のシクロオレフィン系単量体が挙げられる。 Other monomers capable of ring-opening copolymerization with norbornene monomers include cyclohexene, cycloheptene, cyclooctene, 1,4-cyclohexadiene, 1,5-cyclooctadiene, 1,5-cyclodecadiene, And monocyclic cycloolefin monomers such as 1,5,9-cyclododecatriene and 1,5,9,13-cyclohexadecatetraene.

 ノルボルネン系単量体と付加共重合可能なその他の単量体としては、エチレン、プロピレン、1-ブテン、1-ペンテン、1-ヘキセン等の炭素数2~20のα-オレフィン系単量体;シクロブテン、シクロペンテン、シクロヘキセン、シクロオクテン、テトラシクロ[9.2.1.02,10.03,8]テトラデカ-3,5,7,12-テトラエン(3a,5,6,7a-テトラヒドロ-4,7-メタノ-1H-インデンとも言う)等のシクロオレフィン系単量体;1,4-ヘキサジエン、4-メチル-1,4-ヘキサジエン、5-メチル-1,4-ヘキサジエン、1,7-オクタジエン等の非共役ジエン系単量体;等が挙げられる。
 これらの中でも、ノルボルネン系単量体と付加共重合可能なその他の単量体としては、α-オレフィン系単量体が好ましく、エチレンがより好ましい。
 これらのその他の単量体は、置換基を1種又は2種以上有していてもよい。置換基としては、アルキル基、アルキレン基、アリール基、シリル基、アルコキシカルボニル基、アルキリデン基等が挙げられる。
Other monomers capable of addition copolymerization with norbornene monomers include α-olefin monomers having 2 to 20 carbon atoms such as ethylene, propylene, 1-butene, 1-pentene and 1-hexene; cyclobutene, cyclopentene, cyclohexene, cyclooctene, tetracyclo [9.2.1.0 2,10. Cycloolefin monomers such as 0 3,8 ] tetradeca-3,5,7,12-tetraene (also referred to as 3a, 5,6,7a-tetrahydro-4,7-methano-1H-indene); Non-conjugated diene monomers such as 4-hexadiene, 4-methyl-1,4-hexadiene, 5-methyl-1,4-hexadiene, 1,7-octadiene, and the like.
Among these, as other monomers capable of addition copolymerization with norbornene monomers, α-olefin monomers are preferable, and ethylene is more preferable.
These other monomers may have one or more substituents. Examples of the substituent include an alkyl group, an alkylene group, an aryl group, a silyl group, an alkoxycarbonyl group, and an alkylidene group.

 ノルボルネン系単量体の開環重合体、又はノルボルネン系単量体とこれと開環共重合可能なその他の単量体との開環重合体は、単量体成分を、公知の開環重合触媒の存在下で重合して得ることができる。
 開環重合触媒としては、例えば、ルテニウム、オスミウムなどの金属のハロゲン化物と、硝酸塩又はアセチルアセトン化合物、及び還元剤とからなる触媒、あるいは、チタン、ジルコニウム、タングステン、モリブデンなどの金属のハロゲン化物又はアセチルアセトン化合物と、有機アルミニウム化合物とからなる触媒を用いることができる。
 ノルボルネン系単量体の開環重合体水素化物は、通常、上記開環重合体の重合溶液に、ニッケル、パラジウムなどの遷移金属を含む公知の水素化触媒を添加し、炭素-炭素不飽和結合を水素化することにより得ることができる。
A ring-opening polymer of a norbornene-based monomer, or a ring-opening polymer of a norbornene-based monomer and another monomer capable of ring-opening copolymerization with a monomer component is a known ring-opening polymerization. It can be obtained by polymerization in the presence of a catalyst.
Examples of the ring-opening polymerization catalyst include a catalyst comprising a metal halide such as ruthenium or osmium, a nitrate or an acetylacetone compound, and a reducing agent, or a metal halide or acetylacetone such as titanium, zirconium, tungsten, or molybdenum. A catalyst comprising a compound and an organoaluminum compound can be used.
The ring-opening polymer hydride of a norbornene-based monomer is usually obtained by adding a known hydrogenation catalyst containing a transition metal such as nickel or palladium to the polymerization solution of the ring-opening polymer and then adding a carbon-carbon unsaturated bond. Can be obtained by hydrogenation.

 ノルボルネン系単量体の付加重合体、又はノルボルネン系単量体とこれと共重合可能なその他の単量体との付加重合体は、単量体成分を、公知の付加重合触媒の存在下で重合して得ることができる。
 付加重合触媒としては、例えば、チタン、ジルコニウム又はバナジウム化合物と有機アルミニウム化合物とからなる触媒を用いることができる。
An addition polymer of a norbornene monomer, or an addition polymer of a norbornene monomer and another monomer copolymerizable with the norbornene monomer, in the presence of a known addition polymerization catalyst. It can be obtained by polymerization.
As the addition polymerization catalyst, for example, a catalyst composed of a titanium, zirconium or vanadium compound and an organoaluminum compound can be used.

 ノルボルネン系重合体の分子量に格別な制限はないが、シクロヘキサン溶液(重合体が溶解しない場合はトルエン溶液)のゲル・パーミエーション・クロマトグラフィー(GPC)で測定したポリスチレン換算の重量平均分子量で、通常5,000以上であり、好ましくは5,000~500,000、より好ましくは8,000~200,000、特に好ましくは10,000~100,000である。重量平均分子量がこの範囲内であるときに、機械的強度と成形加工性とが高度にバランスし、好適である。 There is no particular restriction on the molecular weight of the norbornene polymer, but it is usually a weight average molecular weight in terms of polystyrene measured by gel permeation chromatography (GPC) of a cyclohexane solution (or a toluene solution if the polymer does not dissolve). It is 5,000 or more, preferably 5,000 to 500,000, more preferably 8,000 to 200,000, and particularly preferably 10,000 to 100,000. When the weight average molecular weight is within this range, the mechanical strength and the moldability are highly balanced, which is preferable.

 ノルボルネン系重合体のガラス転移温度は、使用目的に応じて適宜選択されればよいが、通常50~300℃、好ましくは100~280℃、特に好ましくは115~250℃、さらに好ましくは130~200℃である。ガラス転移温度がこの範囲内であるときに、耐熱性と成形加工性とが高度にバランスし、好適である。
 本発明においてガラス転移温度は、JIS K 7121に基づいて測定されたものである。
The glass transition temperature of the norbornene polymer may be appropriately selected depending on the purpose of use, but is usually 50 to 300 ° C., preferably 100 to 280 ° C., particularly preferably 115 to 250 ° C., and more preferably 130 to 200 ° C. ° C. When the glass transition temperature is within this range, heat resistance and molding processability are highly balanced and suitable.
In the present invention, the glass transition temperature is measured based on JIS K7121.

 ノルボルネン系重合体は、それぞれ単独で、あるいは2種以上を組み合わせて用いることができる。
 また、不織布を構成する樹脂成分として、ノルボルネン系重合体に加えて、任意で、熱可塑性樹脂材料で通常用いられている配合剤、例えば、軟質重合体、酸化防止剤、紫外線吸収剤、光安定剤、近赤外線吸収剤、離型剤、染料や顔料などの着色剤、可塑剤、帯電防止剤、蛍光増白剤などの配合剤を、通常採用される量、添加することができる。ここで、ノルボルネン系重合体に対して軟質重合体を混合して用いる場合には、ノルボルネン系重合体である脂環構造含有重合体100質量部に対して、通常0.01~20質量部、好ましくは0.05~10質量部、より好ましくは0.05~5質量部である。
The norbornene polymers can be used alone or in combination of two or more.
In addition to the norbornene-based polymer as a resin component constituting the nonwoven fabric, optionally, a compounding agent usually used in thermoplastic resin materials, for example, a soft polymer, an antioxidant, an ultraviolet absorber, a light stabilizer Additives, near-infrared absorbers, release agents, colorants such as dyes and pigments, plasticizers, antistatic agents, fluorescent whitening agents, and other compounding agents can be added in the amounts usually employed. Here, when a soft polymer is used in combination with a norbornene polymer, it is usually 0.01 to 20 parts by mass with respect to 100 parts by mass of the alicyclic structure-containing polymer that is a norbornene polymer. The amount is preferably 0.05 to 10 parts by mass, more preferably 0.05 to 5 parts by mass.

 また、不織布を構成する樹脂成分として、ノルボルネン系重合体、及び上述した配合剤の一つである軟質重合体以外に、その他の重合体(以下、単に「その他の重合体」という)を混合しても良い。ノルボルネン系重合体に混合されるその他の重合体の量は、ノルボルネン系重合体100質量部に対して、通常200質量部以下、好ましくは150質量部以下、より好ましくは100質量部以下である。
 ノルボルネン系重合体に対して配合する各種配合剤やその他の重合体の割合が多すぎると細胞が浮遊し難くなるため、いずれもノルボルネン系重合体の性質を損なわない範囲で配合することが好ましい。
In addition to the norbornene polymer and the soft polymer that is one of the above-mentioned compounding agents, other polymers (hereinafter simply referred to as “other polymers”) are mixed as the resin component constituting the nonwoven fabric. May be. The amount of the other polymer mixed with the norbornene polymer is usually 200 parts by mass or less, preferably 150 parts by mass or less, and more preferably 100 parts by mass or less with respect to 100 parts by mass of the norbornene polymer.
If the proportion of various compounding agents and other polymers to be blended with respect to the norbornene polymer is too large, the cells are difficult to float. Therefore, it is preferable to blend them in a range that does not impair the properties of the norbornene polymer.

 ノルボルネン系重合体と、配合剤やその他の重合体との混合方法は、ポリマー中に配合剤が十分に分散する方法であれば、特に限定されない。また、配合の順番に格別な制限はない。配合方法としては、例えば、ミキサー、一軸混練機、二軸混練機、ロール、ブラベンダー、押出機などを用いて樹脂を溶融状態で混練する方法、適当な溶剤に溶解して分散させた後、凝固法、キャスト法、又は直接乾燥法により溶剤を除去する方法などが挙げられる。
 二軸混練機を用いる場合、混練後は、通常は溶融状態で棒状に押出し、ストランドカッターで適当な長さに切り、ペレット化して用いられることが多い。
The mixing method of the norbornene polymer and the compounding agent or other polymer is not particularly limited as long as the compounding agent is sufficiently dispersed in the polymer. Moreover, there is no special restriction | limiting in the order of a mixing | blending. As a blending method, for example, a method of kneading a resin in a molten state using a mixer, a uniaxial kneader, a biaxial kneader, a roll, a Brabender, an extruder, etc., after dissolving and dispersing in a suitable solvent, Examples thereof include a method of removing the solvent by a coagulation method, a casting method, or a direct drying method.
When a biaxial kneader is used, after kneading, it is usually extruded in a rod shape in a molten state, cut into an appropriate length with a strand cutter, and pelletized in many cases.

 本発明に用いる不織布を製造する方法に格別な制限はなく、一般的な不織布の製造方法を採用することができる。
 なかでも、後述する好ましい繊維径、目付量及び表面被覆率を有する不織布を製造する場合、メルトブロー法を用いる方法が好適に採用される。
There is no special restriction | limiting in the method of manufacturing the nonwoven fabric used for this invention, The manufacturing method of a general nonwoven fabric can be employ | adopted.
Especially, when manufacturing the nonwoven fabric which has the preferable fiber diameter mentioned later, a fabric weight, and a surface coverage, the method using a melt blow method is employ | adopted suitably.

 本発明で用いる不織布の繊維径は、好ましくは10~20μmである。ここで繊維径は、不織布の表面をデジタルマイクロスコープVHX-1000(キーエンス社製)を用いて、撮影し、測定した値である。
 不織布の目付量は、好ましくは0.8mg/cm~1.0mg/cmである。ここで目付量は、3cm四方の不織布の重量から単位面積当たりの重量を算出した値である。
 不織布の表面被覆率は、好ましくは50%~95%である。ここで表面被覆率は、前記デジタルマイクロスコープで撮影した画像を、画像解析ソフト(Image J)を用いて、画像全体の面積から繊維が存在していない空隙部を除いた面積を画像全体の面積から除して換算した値である。
The fiber diameter of the nonwoven fabric used in the present invention is preferably 10 to 20 μm. Here, the fiber diameter is a value measured by photographing the surface of the nonwoven fabric using a digital microscope VHX-1000 (manufactured by Keyence Corporation).
The basis weight of the nonwoven fabric is preferably 0.8 mg / cm 2 to 1.0 mg / cm 2 . Here, the basis weight is a value obtained by calculating the weight per unit area from the weight of the 3 cm square nonwoven fabric.
The surface coverage of the nonwoven fabric is preferably 50% to 95%. Here, the surface coverage is the area of the entire image obtained by removing the voids where no fibers are present from the entire area of the image taken with the digital microscope using image analysis software (Image J). It is a value converted by dividing from.

 本発明に用いる不織布は、通常、滅菌処理して用いられる。滅菌処理の方法に格別な制限はなく、高圧蒸気法や乾熱法などの加熱法;γ線や電子線などの放射線を照射する放射線法;高周波を照射する照射法;酸化エチレンガス(EOG)などのガスを接触させるガス法;滅菌フィルタを用いる濾過法;など、医療分野で一般的に採用される方法から、任意に選択することができる。 The nonwoven fabric used in the present invention is usually used after sterilization. There are no particular restrictions on the method of sterilization, heating methods such as the high-pressure steam method and dry heat method; radiation methods that irradiate radiation such as gamma rays and electron beams; irradiation methods that irradiate high frequencies; ethylene oxide gas (EOG) The method can be arbitrarily selected from methods generally employed in the medical field, such as a gas method in which a gas is brought into contact, a filtration method using a sterilizing filter, and the like.

 本発明に用いる不織布上で培養される幹細胞を含む組織由来細胞群は、幹細胞を含む複数種類の細胞を含む組織由来の細胞群であれば、特に限定されない。例えば、細胞治療に供する間葉系血管細胞群、脂肪由来細胞群、骨髄由来細胞群などが挙げられる。また、これらの細胞群から、一部の細胞が既に分離されたものであっても良い。 The tissue-derived cell group containing stem cells cultured on the nonwoven fabric used in the present invention is not particularly limited as long as it is a tissue-derived cell group containing a plurality of types of cells including stem cells. Examples thereof include a mesenchymal vascular cell group, a fat-derived cell group, and a bone marrow-derived cell group that are used for cell therapy. In addition, some cells may be already separated from these cell groups.

 かかる不織布を用いて、組織由来細胞群より幹細胞を分離するための培地は、分離対象となる幹細胞を増殖させることのできる培地を用いれば良く、特に未分化性を維持したまま増殖させることのできる培地を用いるのが好ましい。このような培地は市販されており、例えば、脂肪由来幹細胞であれば、コージンバイオ社製のKBM ADSCシリーズなどが挙げられ、骨髄由来幹細胞であれば、SIGMA-ALDRICH社製のStemline、間葉系幹細胞増殖培地シリーズなどが挙げられる。 The medium for separating the stem cells from the tissue-derived cell group using such a non-woven fabric may be a medium capable of growing the stem cells to be separated, and can be grown particularly while maintaining undifferentiation. It is preferable to use a medium. Such a medium is commercially available. For example, if it is an adipose-derived stem cell, the KBM ADSC series manufactured by Kojin Bio Co., Ltd. can be used. If it is a bone marrow-derived stem cell, Stemline, a mesenchymal system manufactured by SIGMA-ALDRICH Stem cell growth medium series etc. are mentioned.

 培地には、添加剤を配合することもできる。添加剤としては、タンパク質等の誘導因子、ミネラル、金属、ビタミン成分等が挙げられる。
 これらの添加剤は一種単独で、あるいは二種以上を組み合わせて用いることができる。
An additive can also be mix | blended with a culture medium. Examples of additives include inducers such as proteins, minerals, metals, vitamin components, and the like.
These additives can be used alone or in combination of two or more.

 細胞の培養条件は特に限定されず、用いる細胞や目的に応じて適宜決定することができる。
 例えば、二酸化炭素濃度が5%程度で、温度が20℃~37℃の範囲で一定に維持された、加湿された恒温器を用いて細胞を培養することができる。
The cell culture conditions are not particularly limited, and can be appropriately determined according to the cells to be used and the purpose.
For example, the cells can be cultured using a humidified thermostat having a carbon dioxide concentration of about 5% and a constant temperature in the range of 20 ° C. to 37 ° C.

 本発明は、少なくとも培養面がノルボルネン系重合体で構成される不織布上で、組織由来細胞群を培養すると、脂肪幹細胞のみが接着して培養することができ、結果として、脂肪幹細胞を分離することができるというものである。 In the present invention, when a tissue-derived cell group is cultured on a nonwoven fabric having at least a culture surface made of a norbornene polymer, only adipose stem cells can be adhered and cultured, and as a result, adipose stem cells are separated. It can be done.

 分離された幹細胞は、幹細胞治療用途に用いるほか、更に分化誘導培地にて培養することにより分化細胞を得、創薬用途や医療用途に利用することができる。 The isolated stem cells can be used for stem cell therapy, and further cultured in a differentiation-inducing medium to obtain differentiated cells, which can be used for drug discovery and medical applications.

 本発明の方法により単離された幹細胞を分化誘導する場合に用いられる培地は、幹細胞の分化誘導に適した培地を用いれば良く、基礎培地に分化誘導するための添加剤を加えた培地や、市販の分化誘導培地を用いることができる。 The medium used in inducing differentiation of the stem cells isolated by the method of the present invention may be a medium suitable for inducing differentiation of stem cells, a medium to which an additive for inducing differentiation into a basal medium is added, A commercially available differentiation induction medium can be used.

 分化誘導するための添加剤としては、細胞表面の受容体に作用する、リガンド、アゴニスト、アンタゴニスト;核内受容体の、リガンド、アゴニスト、アンタゴニスト;コラーゲンやファイブネクチンなどの細胞外マトリックス;細胞外マトリックスの一部分あるいは、模擬した化合物;細胞内の情報伝達経路に関わるタンパク質に作用する成分;細胞内の1次代謝又は2次代謝の酵素に作用する成分;細胞内の核内又はミトコンドリア内の遺伝子の発現に影響を与える成分;ウィルスベクターなどと組み合わせて細胞内に導入することができるDNAやRNA;等が挙げられる。
 これらの添加剤は、一種単独で、あるいは二種以上を組み合わせて用いることができる。
 市販の分化誘導培地としては、R&D Systems社製「Stem Cell Kits」などが挙げられる。
Additives for inducing differentiation include ligands, agonists and antagonists acting on cell surface receptors; nuclear receptors, ligands, agonists and antagonists; extracellular matrix such as collagen and fivenectin; extracellular matrix A compound that acts on a protein involved in an intracellular signal transduction pathway; a component that acts on an enzyme of primary or secondary metabolism in a cell; a gene in a nucleus or mitochondrion in a cell Examples include components that affect expression; DNA and RNA that can be introduced into cells in combination with viral vectors and the like.
These additives can be used alone or in combination of two or more.
Examples of the commercially available differentiation induction medium include “Stem Cell Kits” manufactured by R & D Systems.

 細胞の培養条件は特に限定されず、用いる細胞や目的に応じて適宜決定することができる。
 例えば、二酸化炭素濃度が5%程度で、温度が20℃~37℃の範囲で一定に維持された、加湿された恒温器を用いて細胞を培養することができる。
The cell culture conditions are not particularly limited, and can be appropriately determined according to the cells to be used and the purpose.
For example, the cells can be cultured using a humidified thermostat having a carbon dioxide concentration of about 5% and a constant temperature in the range of 20 ° C. to 37 ° C.

 以下、本発明を、実施例によりさらに詳細に説明する。但し、本発明は以下の実施例により何ら限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to examples. However, the present invention is not limited to the following examples.

<ノルボルネン系重合体で構成される不織布>
 ノルボルネン系重合体(ゼオノア(登録商標)1060R、日本ゼオン社製;ノルボルネン系開環重合体水素化物)、及び、ノルボルネン系重合体(ゼオネックス(登録商標)5000、日本ゼオン社製;ノルボルネン系開環重合体水素化物)を用いて、メルトブロー法で、以下の条件により、ゼオノア(登録商標)1060R製の不織布(以下「ゼオノア不織布」という)、及び、ゼオネックス(登録商標)5000製の、2種の不織布(以下、「ゼオネックス不織布1」、「ゼオネックス不織布2」という)を、それぞれ作製した。
<Nonwoven fabric composed of norbornene polymer>
Norbornene-based polymer (Zeonor (registered trademark) 1060R, manufactured by Nippon Zeon Co., Ltd .; norbornene-based ring-opening polymer hydride), and norbornene-based polymer (Zeonex (registered trademark) 5000, manufactured by Nippon Zeon Co., Ltd .; norbornene-based ring opening Polymer hydride) is used in a melt-blowing method under the following conditions: a nonwoven fabric made of ZEONOR (registered trademark) 1060R (hereinafter referred to as "ZEONOR nonwoven fabric") and two types of products made of ZEONEX (registered trademark) 5000 Nonwoven fabrics (hereinafter referred to as “ZEONEX nonwoven fabric 1” and “ZEONEX nonwoven fabric 2”) were produced.

<ゼオノア不織布>
・樹脂:ゼオノア(登録商標)1060R
・ノズル温度:293℃
・ダイス温度:298℃
・回転数:100rpm
・コンベアースピード:14.5m/min
・紡糸口金からコレクターまでの距離(以下、「DCD」という):45mm
<Zeonoa non-woven fabric>
Resin: ZEONOR (registered trademark) 1060R
・ Nozzle temperature: 293 ℃
-Die temperature: 298 ° C
・ Rotation speed: 100rpm
・ Conveyor speed: 14.5m / min
・ Distance from the spinneret to the collector (hereinafter referred to as “DCD”): 45 mm

<ゼオネックス不織布1>
・樹脂:ゼオネックス(登録商標)5000
・ノズル温度:300℃
・ダイス温度:290℃
・回転数:100rpm
・コンベアースピード:14.2m/min
・DCD:85mm
<ZEONEX nonwoven fabric 1>
Resin: Zeonex (registered trademark) 5000
・ Nozzle temperature: 300 ℃
-Die temperature: 290 ° C
・ Rotation speed: 100rpm
・ Conveyor speed: 14.2 m / min
DCD: 85mm

<ゼオネックス不織布2>
・樹脂:ゼオネックス(登録商標)5000
・ノズル温度:298℃
・ダイス温度:290℃
・回転数:100rpm
・コンベアースピード:14.2m/min
・DCD:52mm
<ZEONEX nonwoven fabric 2>
Resin: Zeonex (registered trademark) 5000
・ Nozzle temperature: 298 ℃
-Die temperature: 290 ° C
・ Rotation speed: 100rpm
・ Conveyor speed: 14.2 m / min
DCD: 52mm

 得られた不織布の繊維径、目付量及び表面被覆率は以下の通りである。
・ゼオノア不織布:繊維径10.05μm、目付量0.98mg/cm、表面被覆率91%
・ゼオネックス不織布1:繊維径15.05μm、目付量0.94mg/cm、表面被覆率58%
・ゼオネックス不織布2:繊維径13.33μm、目付量0.81mg/cm、表面被覆率82%
The fiber diameter, basis weight, and surface coverage of the obtained nonwoven fabric are as follows.
・ Zeonoa nonwoven fabric: Fiber diameter 10.05 μm, basis weight 0.98 mg / cm 2 , surface coverage 91%
ZEONEX nonwoven fabric 1: Fiber diameter 15.05 μm, basis weight 0.94 mg / cm 2 , surface coverage 58%
ZEONEX nonwoven fabric 2: fiber diameter 13.33 μm, basis weight 0.81 mg / cm 2 , surface coverage 82%

[実施例1]
<脂肪組織からのASCの分離>
 ヒトより摘出した直径約3mmの脂肪組織を4分割し、このものを直径2cmの円形に切り取られたゼオノア不織布及びゼオネックス不織布2に乗せた後、この組織が乗った不織布をそれぞれ別の細胞培養用ポリスチレン製ディッシュ(FALCON(登録商標)、コーニング社製、直径35mmのTCPS)に入れた。
 その後、当該ディッシュに、2%ウシ胎児血清(FBS)を添加した間葉系幹細胞増殖培地(Stemline(登録商標)、シグマアルドリッチ社製)を入れ、5%CO雰囲気37℃の条件で培養した。
 いずれの不織布上でも、7~10日後に、脂肪組織由来幹細胞(ASC)が分離増殖し始めたのが確認できた。ASCの分離増殖を確認したら培地を交換し、培養を継続し、培養開始から18日後、ASCを不織布からトリプシン-EDTAで剥がした後、279.8mLの細胞培養用フラスコ(型番「T-75」、エッペンドルフ社製)に移し、同じ培地で4日間継代培養すると90%コンフルエントになった。
 ゼオノア不織布及びゼオネックス不織布2上に増殖している培養開始から18日後のASCの位相差顕微鏡写真(倍率64倍)を図1及び図2に示す。いずれの不織布上にもASCが増殖していることが確認される。
 また、細胞培養用フラスコに移して4日間継代培養した時の位相差顕微鏡写真(倍率64倍)を図3に示す。ASCが増殖していることが確認される。
[Example 1]
<Separation of ASC from adipose tissue>
A fat tissue with a diameter of about 3 mm extracted from a human is divided into four parts, and this is placed on a ZEONOR nonwoven fabric and a ZEONEX nonwoven fabric 2 cut into a circular shape with a diameter of 2 cm. It was put in a polystyrene dish (FALCON (registered trademark), Corning, TCPS having a diameter of 35 mm).
Thereafter, a mesenchymal stem cell growth medium (Stemline (registered trademark), manufactured by Sigma-Aldrich) supplemented with 2% fetal bovine serum (FBS) was added to the dish, and cultured at 37 ° C. in a 5% CO 2 atmosphere. .
It was confirmed that adipose tissue-derived stem cells (ASC) began to separate and proliferate after 7 to 10 days on any nonwoven fabric. After confirming the ASC separation and growth, the medium was changed, and the culture was continued. After 18 days from the start of the culture, the ASC was peeled off from the nonwoven fabric with trypsin-EDTA, and then a 279.8 mL flask for cell culture (model number “T-75”). And then subcultured for 4 days in the same medium, it became 90% confluent.
A phase contrast micrograph (magnification 64 times) of ASC 18 days after the start of culture growing on the Zeonore nonwoven fabric and the Zeonex nonwoven fabric 2 is shown in FIGS. It is confirmed that ASC is proliferating on any nonwoven fabric.
Further, FIG. 3 shows a phase contrast micrograph (magnification 64 times) when transferred to a cell culture flask and subcultured for 4 days. It is confirmed that ASC is proliferating.

[実施例2]
<骨髄液からのBMSCの分離>
 ヒトより採取した骨髄液10mlに、Hanks Balanced Salt Solution(HBSS)を当量加え、良く攪拌して骨髄液希釈液を調製した。直径2cmの円形に切り取られたゼオノア不織布及びゼオネックス不織布1を、100μmのセルストレーナー(Falcon(登録商標)型番352360、コーニング社製)にそれぞれセットし、先に調製した骨髄液希釈液を通し、HBSSで2回洗浄した後、不織布をそれぞれ別の細胞培養用ポリスチレン製ディッシュ(FALCON(登録商標)、コーニング社製、直径35mmのTCPS)に入れた。その後、当該ディッシュに、2%ウシ胎児血清(FBS)を添加した間葉系幹細胞増殖培地(Stemline(登録商標);シグマアルドリッチ社製)を入れ、5%CO雰囲気37℃の条件で培養した。
 いずれの不織布でも、7~10日後に、骨髄由来幹細胞(BMSC)が分離増殖し始めたのが確認できた。BMSCの分離増殖を確認した後、培地を交換し、さらに培養を継続した。培養開始から18日後、BMSCを不織布からトリプシン-EDTAで剥がした後、279.8mLの細胞培養用フラスコ(型番「T-75」、エッペンドルフ社製)に移し、同じ培地で、4日間継代培養すると90%コンフルエントになった。
 ゼオノア不織布及びゼオネックス不織布1上に増殖している、培養開始から18日後のBMSCの位相差顕微鏡写真(倍率64倍)を図4及び図5に示す。いずれの不織布上にもBMSCが増殖していることが確認される。
 また、このBMSCを細胞培養用フラスコに移して4日間継代培養したときの位相差顕微鏡写真(倍率64倍)を図6に示す。BMSCが増殖していることが確認される。
[Example 2]
<Separation of BMSC from bone marrow fluid>
An equivalent amount of Hanks Balanced Salt Solution (HBSS) was added to 10 ml of bone marrow fluid collected from humans and stirred well to prepare a diluted bone marrow fluid. The ZEONOR nonwoven fabric and ZEONEX nonwoven fabric 1 cut into a circle with a diameter of 2 cm were respectively set on a 100 μm cell strainer (Falcon (registered trademark) model number 352360, manufactured by Corning), and the bone marrow fluid diluted solution previously prepared was passed through the HBSS. After washing twice, the nonwoven fabrics were placed in separate polystyrene dishes for cell culture (FALCON (registered trademark), Corning, TCPS with a diameter of 35 mm). Thereafter, a mesenchymal stem cell growth medium (Stemline (registered trademark); manufactured by Sigma-Aldrich) supplemented with 2% fetal bovine serum (FBS) was added to the dish, and cultured under conditions of 37 ° C. in a 5% CO 2 atmosphere. .
In any nonwoven fabric, it was confirmed that bone marrow-derived stem cells (BMSC) began to separate and proliferate after 7 to 10 days. After confirming the isolated growth of BMSC, the medium was changed, and the culture was further continued. 18 days after the start of culture, BMSC was peeled off from the nonwoven fabric with trypsin-EDTA, transferred to a 279.8 mL flask for cell culture (model number “T-75”, manufactured by Eppendorf), and subcultured for 4 days in the same medium. It was 90% confluent.
4 and 5 show phase contrast micrographs (magnification 64 times) of BMSC grown on the Zeonore nonwoven fabric and the Zeonex nonwoven fabric 1 after 18 days from the start of culture. It is confirmed that BMSC is proliferating on any nonwoven fabric.
Further, FIG. 6 shows a phase contrast micrograph (magnification 64 times) when this BMSC was transferred to a cell culture flask and subcultured for 4 days. It is confirmed that BMSC is proliferating.

[比較例]
 中芯ポリエチレン外層ポリプロピレン不織布(10mm×32mm)を6穴プレート入れ、そこにBMSCの懸濁液、3mL(0.45×10cells/mL)を添加し、3日間培養した。培地は2%FBSを添加した間葉系幹細胞増殖培地〔シグマアルドリッチ社製、Stemline(登録商標)〕を用いた。
 その結果、中芯ポリエチレン外層ポリプロピレン不織布上には、MSCが僅かに接着しているだけで(図7)、プレート底面には100%コンフルエントな状態で接着しており(図8)、幹細胞の分離効果が得られなかった。
[Comparative example]
A 6-well plate was placed in a core polyethylene outer layer polypropylene non-woven fabric (10 mm × 32 mm), and a suspension of BMSC, 3 mL (0.45 × 10 6 cells / mL) was added thereto and cultured for 3 days. The medium was a mesenchymal stem cell growth medium (Sigma Aldrich, Stemline (registered trademark)) supplemented with 2% FBS.
As a result, MSC was only slightly adhered on the core polyethylene outer layer polypropylene non-woven fabric (FIG. 7) and adhered to the bottom surface of the plate in a 100% confluent state (FIG. 8). The effect was not obtained.

[実施例3]
 実施例1において、ゼオノア不織布及びゼオネックス不織布2上で分離され、その後継代されたASC(以下、「継代ASC)という)の分化誘導実験を、以下の通り行った。
(1)脂肪細胞への分化
 継代ASCを24ウェルマルチプレート(FALCON(登録商標)型番353047、コーニング社製)に、1.9×10cells/wellで播種し、2%ウシ胎児血清(FBS)を添加した間葉系幹細胞増殖培地(Stemline(登録商標)、シグマアルドリッチ社製)を入れ、5%CO雰囲気37℃の条件で培養した。24時間後、培地を捨て、リン酸緩衝液(PBS)で2回洗浄してから、脂肪細胞分化培地(型番BBDM2、DSファーマバイオメディカル社製)に交換して1週間培養した。その後、脂肪細胞培養用培地(型番BBAM1、DSファーマバイオメディカル社製)に交換して、1週間培養した後、Oil-Red染色した。脂肪細胞が染色された顕微鏡写真を図9に示す。
 図9から、Oil-Red染色された脂肪滴を持つ脂肪細胞が見られ、実施例1で得られた継代ASCは、脂肪細胞への分化能を有することが確認された。
[Example 3]
In Example 1, the differentiation induction experiment of ASC separated on the ZEONOR nonwoven fabric and the ZEONEX nonwoven fabric 2 and then passaged (hereinafter referred to as “passage ASC”) was performed as follows.
(1) Differentiation into adipocytes Passage ASC was seeded on a 24-well multiplate (FALCON (registered trademark) model No. 353047, manufactured by Corning) at 1.9 × 10 5 cells / well, and 2% fetal bovine serum ( A mesenchymal stem cell growth medium (Stemline (registered trademark), manufactured by Sigma-Aldrich) supplemented with FBS) was added and cultured under conditions of 37 ° C. in a 5% CO 2 atmosphere. After 24 hours, the medium was discarded, washed twice with a phosphate buffer (PBS), replaced with an adipocyte differentiation medium (model number BBDM2, DS Pharma Biomedical), and cultured for 1 week. Thereafter, the medium was replaced with an adipocyte culture medium (model number BBAM1, manufactured by DS Pharma Biomedical Co., Ltd.), cultured for 1 week, and then stained with Oil-Red. A photomicrograph of stained adipocytes is shown in FIG.
From FIG. 9, fat cells with oil-red stained lipid droplets were observed, and it was confirmed that the passage ASC obtained in Example 1 had the ability to differentiate into adipocytes.

(2)骨芽細胞への分化
 継代ASCを24ウェルマルチプレート(FALCON(登録商標)型番353047、コーニング社製)に、1.5×10cells/wellで播種し、2%ウシ胎児血清(FBS)を添加した間葉系幹細胞増殖培地(Stemline(登録商標)、シグマアルドリッチ社製)を入れ、5%CO雰囲気37℃の条件で培養した。その後、培地を骨芽細胞分化培地(型番BBOB1、DSファーマバイオメディカル社製)に交換して、細胞の密集度60%程度(約60%confluency)で2週間培養した。その後、細胞をAlizarin Red染色した。骨芽細胞が染色された顕微鏡写真を図10に示す。
 図10から、細胞とその周囲がAlizarin Redで薄い赤で染色されたことから、カルシウムの沈着が認められ、実施例1で得られた継代ASCは、骨芽細胞への分化能も有することが確認された。
(2) Differentiation into osteoblasts Passage ASC was seeded on a 24-well multiplate (FALCON (registered trademark) model No. 353047, manufactured by Corning) at 1.5 × 10 4 cells / well, and 2% fetal bovine serum A mesenchymal stem cell growth medium (Stemline (registered trademark), manufactured by Sigma-Aldrich Co.) supplemented with (FBS) was added and cultured under conditions of 37 ° C. in a 5% CO 2 atmosphere. Thereafter, the medium was replaced with an osteoblast differentiation medium (model number BBOB1, manufactured by DS Pharma Biomedical Co., Ltd.), and cultured at a cell density of about 60% (about 60% confluency) for 2 weeks. Thereafter, the cells were stained with Alizarin Red. FIG. 10 shows a photomicrograph of stained osteoblasts.
From FIG. 10, since the cells and their surroundings were stained with Alizarin Red in light red, calcium deposition was observed, and the passage ASC obtained in Example 1 also has the ability to differentiate into osteoblasts. Was confirmed.

(3)軟骨細胞への分化
 24ウェルマルチプレート(FALCON(登録商標)型番353047、コーニング社製)に、1.6×10cells/mLに調製した継代ASCを5μL滴下して、2時間後に、軟骨細胞分化培地(StemPro Chondrogenesis differentation Kit;型番A10070-01、コーニング社製)を添加し、5%CO雰囲気37℃の条件で培養した。その後、4~5日間隔で培地交換しながら2週間培養した。得られた細胞をAlcian Blue染色した。軟骨細胞が染色された顕微鏡写真を図11に示す。
 図11から、細胞とその周囲がAlcian Blueで青く染色されたことから、軟骨に多く含まれる酸性ムコ多糖の沈着が認められ、実施例1で得られた継代ASCは、軟骨細胞への分化能も有することが確認された。
(3) Differentiation into chondrocytes 5 μL of passage ASC prepared at 1.6 × 10 7 cells / mL was dropped on a 24-well multiplate (FALCON (registered trademark) model number 353047, manufactured by Corning) for 2 hours. Later, a chondrocyte differentiation medium (StemPro Chronogenesis differentiation Kit; model number A10070-01, manufactured by Corning) was added, and the cells were cultured under conditions of 37 ° C. in a 5% CO 2 atmosphere. Thereafter, the cells were cultured for 2 weeks while changing the medium at intervals of 4 to 5 days. The obtained cells were stained with Alcian Blue. A photomicrograph in which chondrocytes are stained is shown in FIG.
From FIG. 11, since the cells and their surroundings were stained blue with Alcian Blue, the deposition of acidic mucopolysaccharides abundant in cartilage was observed, and the passage ASC obtained in Example 1 differentiated into chondrocytes. It was confirmed that it also has a function.

(4)神経細胞への分化
 継代ASCを24ウェルマルチプレート(FALCON(登録商標)型番353047、コーニング社製)に、4.8×10cells/wellで播種し、2%ウシ胎児血清(FBS)を添加した間葉系幹細胞増殖培地(Stemline(登録商標)、シグマアルドリッチ社製)を入れ、5%CO雰囲気37℃の条件で培養した。培養を開始してから48時間後、培地を捨て、リン酸緩衝液(PBS)で2回洗浄してから、神経細胞分化培地(HyClone AdvanceSTEM Neural Differentiation Kit、サーモ・フィッシャー・サイエンティフィック社製)に交換して、細胞の密集度30%程度(約30%confluency)で2日間培養したところ、神経突起が確認できた。そこで、Alexa Fluor(登録商標)488(サーモ・フィッシャー・サイエンティフィック社製)でラベリングした、マウス抗β-Tubulin Class III抗体(フナコシ社より入手)で蛍光染色した。神経細胞が染色された蛍光顕微鏡写真を図12に示す。
 図12から、細胞体及び突起が緑色に染色されていることから、成熟哺乳動物の神経細胞であることが認められ、実施例1で得られた継代ASCは、神経細胞への分化能も有することが確認された。
(4) Differentiation into nerve cells Passage ASC was seeded on a 24-well multiplate (FALCON (registered trademark) model No. 353047, manufactured by Corning) at 4.8 × 10 3 cells / well, and 2% fetal bovine serum ( A mesenchymal stem cell growth medium (Stemline (registered trademark), manufactured by Sigma-Aldrich) supplemented with FBS) was added and cultured under conditions of 37 ° C. in a 5% CO 2 atmosphere. 48 hours after the start of the culture, the medium was discarded and washed twice with a phosphate buffer (PBS), and then a neuronal differentiation medium (HyClone Advance STEM Neural Differentiation Kit, manufactured by Thermo Fisher Scientific) When the cells were cultured at a cell density of about 30% (about 30% confluency) for 2 days, neurites could be confirmed. Therefore, the cells were fluorescently stained with mouse anti-β-tubulin class III antibody (obtained from Funakoshi) labeled with Alexa Fluor (registered trademark) 488 (manufactured by Thermo Fisher Scientific). FIG. 12 shows a fluorescence micrograph in which nerve cells are stained.
From FIG. 12, since the cell bodies and processes are stained green, it is recognized that the cells are mature mammalian neurons, and the passage ASC obtained in Example 1 also has the ability to differentiate into neurons. It was confirmed to have.

 以上の結果から、少なくとも培養面がノルボルネン系重合体で構成される不織布を用いることで、組織から幹細胞を容易に単離し、増殖させることができること、増殖させた幹細胞が高い分化能を有することがわかる。 From the above results, it is possible to easily isolate and proliferate stem cells from tissues by using a nonwoven fabric having at least a culture surface made of a norbornene polymer, and that the proliferated stem cells have high differentiation ability. Recognize.

Claims (3)

 幹細胞を含む組織由来細胞群を、少なくとも培養面がノルボルネン系重合体で構成される不織布上で培養する、幹細胞の分離方法。 A method for separating stem cells, wherein a tissue-derived cell group containing stem cells is cultured on a nonwoven fabric having at least a culture surface made of a norbornene polymer.  組織由来細胞群が、脂肪組織由来である請求項1記載の幹細胞の分離方法。 The method for separating stem cells according to claim 1, wherein the tissue-derived cell group is derived from adipose tissue.  幹細胞を含む組織由来細胞群から幹細胞を分離するための、少なくとも培養面がノルボルネン系重合体で構成される不織布の使用。 Use of a nonwoven fabric in which at least the culture surface is composed of a norbornene polymer for separating stem cells from a tissue-derived cell group containing stem cells.
PCT/JP2017/042042 2016-11-24 2017-11-22 Stem cell isolation method and use of nonwoven fabric formed of norbornene-based polymer Ceased WO2018097189A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018552623A JP7018650B2 (en) 2016-11-24 2017-11-22 Stem cell separation method and use of non-woven fabric composed of norbornene-based polymer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016228099 2016-11-24
JP2016-228099 2016-11-24

Publications (1)

Publication Number Publication Date
WO2018097189A1 true WO2018097189A1 (en) 2018-05-31

Family

ID=62196214

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/042042 Ceased WO2018097189A1 (en) 2016-11-24 2017-11-22 Stem cell isolation method and use of nonwoven fabric formed of norbornene-based polymer

Country Status (2)

Country Link
JP (1) JP7018650B2 (en)
WO (1) WO2018097189A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008017839A (en) * 2006-06-16 2008-01-31 Nipro Corp Cell culture container, method for producing the same, and cell culture method
JP2009106160A (en) * 2007-10-26 2009-05-21 Nipro Corp Cell culture container and cell culture method
JP2012044970A (en) * 2010-08-30 2012-03-08 Tokyo Univ Of Agriculture & Technology Method for producing cell sheet for transplantation, cell sheet for transplantation, and method for treating using cell sheet for transplantation
WO2016121775A1 (en) * 2015-01-26 2016-08-04 宇部興産株式会社 Cell culturing method and kit

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008017839A (en) * 2006-06-16 2008-01-31 Nipro Corp Cell culture container, method for producing the same, and cell culture method
JP2009106160A (en) * 2007-10-26 2009-05-21 Nipro Corp Cell culture container and cell culture method
JP2012044970A (en) * 2010-08-30 2012-03-08 Tokyo Univ Of Agriculture & Technology Method for producing cell sheet for transplantation, cell sheet for transplantation, and method for treating using cell sheet for transplantation
WO2016121775A1 (en) * 2015-01-26 2016-08-04 宇部興産株式会社 Cell culturing method and kit

Also Published As

Publication number Publication date
JP7018650B2 (en) 2022-02-14
JPWO2018097189A1 (en) 2019-10-17

Similar Documents

Publication Publication Date Title
US12251397B2 (en) Cross-linked hyaluronic acids and combinations with PRP/BMC
Li et al. Direct fabrication of a hybrid cell/hydrogel construct by a double-nozzle assembling technology
Faroni et al. Self‐assembling peptide hydrogel matrices improve the neurotrophic potential of human adipose‐derived stem cells
Yao et al. Injectable cell/hydrogel microspheres induce the formation of fat lobule-like microtissues and vascularized adipose tissue regeneration
US11998658B2 (en) Injectable porous hydrogels
TWI374743B (en) Composite for thermo-sensitive cell-tissue transplanted scaffold and use thereof
Yi et al. Bioreactor synergy with 3D scaffolds: new era for stem cells culture
Gao et al. Neuronal cell differentiation of human dental pulp stem cells on synthetic polymeric surfaces coated with ECM proteins
AU2017290569A1 (en) Spheroids including biologically-relevant materials and related methods
Thorp et al. Enhancing chondrogenic potential via mesenchymal stem cell sheet multilayering
Lech et al. Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton's Jelly (WJ-MSCs)
Lam et al. Sub-confluent culture of human mesenchymal stromal cells on biodegradable polycaprolactone microcarriers enhances bone healing of rat calvarial defect
EP3162891B1 (en) Cultured cell differentiation promotion method and cultured cell differentiation promoter
Paduszyński et al. Changes in expression of cartilaginous genes during chondrogenesis of Wharton’s jelly mesenchymal stem cells on three-dimensional biodegradable poly (L-lactide-co-glycolide) scaffolds
Di Stefano et al. Systematic review on spheroids from adipose‐derived stem cells: Spontaneous or artefact state?
WO2018066512A1 (en) Method for separating stem cells, method for inducing differentiation and utilization of cell culture container
JP2013511314A (en) Graft composition for nerve tissue regeneration and its manufacture and use
Rezaei et al. Improving the growth rate of human adipose-derived mesenchymal stem cells in alginate/gelatin versus alginate hydrogels
JP7018650B2 (en) Stem cell separation method and use of non-woven fabric composed of norbornene-based polymer
JP6954121B2 (en) Method for promoting differentiation of cultured cells and agent for promoting differentiation of cultured cells
JP2018201394A (en) Cell sheet manufacturing method
Li et al. Substance P-induced RAD16-I scaffold mediated hUCMSCs stereo-culture triggers production of mineralized nodules and collagen-like fibers by promoting osteogenic genes expression
TW202042823A (en) Cross-linked hyaluronic acids and combinations with prp/bmc
Shivachar Isolation and culturing of glial, neuronal and neural stem cell types encapsulated in biodegradable peptide hydrogel
Wang et al. Bioengineering approaches to accelerate clinical translation of stem cell therapies treating osteochondral diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17874818

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2018552623

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17874818

Country of ref document: EP

Kind code of ref document: A1